Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial - 03/09/11

Sana M. Al-Khatib, MD, MHS ^a, ⁎ , Karen S. Pieper, MS ^a, Kerry L. Lee, PhD ^a, Kenneth W. Mahaffey, MD ^a, Judith S. Hochman, MD ^b, Carl J. Pepine, MD ^c, Stephen L. Kopecky, MD ^d, Martijn Akkerhuis, MD ^e, Janina Stepinska, MD ^f, Maarten L. Simoons, MD ^g, Eric J. Topol, MD ^h, Robert M. Califf, MD ^a, Robert A. Harrington, MD ^a

^a Duke Clinical Research Institute, Durham, North Carolina, USA 

^b St. Luke’s-Roosevelt Medical Center, New York, New York, USA 

^c University of Florida College of Medicine, Gainesville, Florida, USA 

^d Mayo Clinic Foundation, Rochester, Minnesota, USA 

^e Cardialysis, Rotterdam, The Netherlands 

^f National Institute of Cardiology, Warsaw, Poland 

^g Thoraxcenter, Rotterdam, The Netherlands 

^h Cleveland Clinic Foundation, Cleveland, Ohio, USA 

^*Dr. Al-Khatib’s address is: Duke Clinical Research Institute, P.O. Box 17969, Durham, North Carolina 27715